Insider · CIK 0001184627
FENTON DENNIS M
Reports to the SEC for 11 companies · SAN DIEGO, CA
Transactions
50
Companies
11
Filings
5
CIK
0001184627
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-15 | TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion | — |
| 2026-06-15 | TRAXFirst Tracks Biotherapeutics, Inc.M Exercise/Conversion | — |
| 2026-05-12 | TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award | — |
| 2026-05-12 | TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award | — |
| 2026-05-12 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-05-12 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-04-20 | TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-01-06 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2026-01-06 | ANABANAPTYSBIO, INC · Restricted Stock UnitA Award | — |
| 2025-06-18 | ANABANAPTYSBIO, INCS Sale | −$72.3K |
| 2025-06-15 | ANABANAPTYSBIO, INCM Exercise/Conversion | — |
| 2025-06-15 | ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion | — |
| 2025-01-07 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2025-01-07 | ANABANAPTYSBIO, INC · Restricted Stock UnitA Award | — |
| 2024-06-21 | ANABANAPTYSBIO, INCS Sale | −$45.2K |
| 2024-06-15 | ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion | — |
| 2024-06-15 | ANABANAPTYSBIO, INCM Exercise/Conversion | — |
| 2024-01-03 | ANABANAPTYSBIO, INC · Restricted Stock UnitA Award | — |
| 2024-01-03 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2023-01-06 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2023-01-06 | ANABANAPTYSBIO, INC · Restricted Stock UnitA Award | — |
| 2022-02-10 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2021-02-10 | ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award | — |
| 2020-07-02 | PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | −$682.62 |
| 2020-07-02 | PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-07-02 | PORTOLA PHARMACEUTICALS INCD Disposition to Issuer | −$131K |
| 2020-07-02 | PORTOLA PHARMACEUTICALS INCD Disposition to Issuer | −$237K |
| 2020-06-12 | PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2020-06-12 | PORTOLA PHARMACEUTICALS INCA Award | — |
| 2020-02-12 | ANABANAPTYSBIO, INC · Director Stock Option (Right to Buy)A Award | — |
| 2019-06-13 | PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2019-06-13 | PORTOLA PHARMACEUTICALS INCA Award | — |
| 2019-05-30 | Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award | — |
| 2019-02-08 | ANABANAPTYSBIO, INC · Director Stock Option (Right to Buy)A Award | — |
| 2018-06-08 | PORTOLA PHARMACEUTICALS INCA Award | — |
| 2018-06-08 | PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2018-06-01 | Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award | — |
| 2018-03-05 | ANABANAPTYSBIO, INC · Director Stock Option (right to buy)A Award | — |
| 2018-03-05 | ANABANAPTYSBIO, INC · Director Stock Option (right to buy)A Award | — |
Recent filings
- 4FENTON DENNIS M0001184627-26-000007SEC(opens sec.gov)
- 4/AFENTON DENNIS M0001184627-26-000006SEC(opens sec.gov)
- 4FENTON DENNIS M0001184627-26-000005SEC(opens sec.gov)
- 4FENTON DENNIS M0001184627-26-000004SEC(opens sec.gov)
- 4FENTON DENNIS M0001184627-26-000001SEC(opens sec.gov)
Companies
- AMGEN INCExecutive V.P., OperationsAMGN
- ANAPTYSBIO, INCDirectorANAB
- DENDREON CORPDirector
- First Tracks Biotherapeutics, Inc.DirectorTRAX
- GENZYME CORPDirector
- HOSPIRA INCDirector
- KYTHERA BIOPHARMACEUTICALS INCDirector
- Pfenex Inc.Director
- PORTOLA PHARMACEUTICALS INCDirector
- Sienna Biopharmaceuticals, Inc.Director
- XENOPORT INCDirector
Address
10770 WATERIDGE CIRCLE, SUITE 210
SAN DIEGO, CA, 92121